Arthropod-Borne Flaviviruses and RNA Interference: Seeking New Approaches for Antiviral Therapy

ABSTRACT: Flaviviruses are the most prevalent arthropod-borne viruses worldwide, and nearly half of the 70 Flavivirus members identified are human pathogens. Despite the huge clinical impact of flaviviruses, there is no specific human antiviral therapy available to treat infection with any of the fl...

Full description

Autores:
Diosa Toro, Mayra Alejandra
Urcuqui Inchima, Silvio
Smit, Jolanda M
Tipo de recurso:
Article of investigation
Fecha de publicación:
2013
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/39555
Acceso en línea:
https://hdl.handle.net/10495/39555
Palabra clave:
Flavivirus
Interferencia de ARN
RNA Interference
Culicidae
Infecciones por Flavivirus
Flavivirus Infections
https://id.nlm.nih.gov/mesh/D005416
https://id.nlm.nih.gov/mesh/D034622
https://id.nlm.nih.gov/mesh/D009033
https://id.nlm.nih.gov/mesh/D018177
Rights
openAccess
License
Derechos reservados - Está prohibida la reproducción parcial o total de esta publicación
Description
Summary:ABSTRACT: Flaviviruses are the most prevalent arthropod-borne viruses worldwide, and nearly half of the 70 Flavivirus members identified are human pathogens. Despite the huge clinical impact of flaviviruses, there is no specific human antiviral therapy available to treat infection with any of the flaviviruses. Therefore, there is a continued search for novel ther apies, and this review describes the current knowledge on the usage of RNA interference (RNAi) in combating flavivirus infections. RNAi is a process of sequence- specific gene silencing triggered by double-stranded RNA. Antiviral RNAi strategies against arthropod-borne flaviviruses have been reported and although several hurdles must be overcome to employ this technology in clinical applications, they potentially represent a new therapeutic tool.